Live Investment Opportunity | Minimum $100 | Join Early Backers Investing Today

The World's First Multi-Drug Breathalyzer Will Save Lives - And You Can Be Part of It

Epinal is changing public safety with revolutionary breath-detection technology that uncovers narcotics in minutes not hours or days offering a faster, smarter, and more efficient approach to drug testing.

Get Campaign Updates

Receive field-trial news, partnerships, and
funding progress

Meet Mark Wong CEO & Co-Founder

I spent 20 years building companies in the tech and semiconductor industries. But nothing has felt as urgent or as important as Epinal.

My co-founder Mike and I started Epinal because we saw a terrifying gap in public safety there was no way to rapidly detect narcotics in the field. Law enforcement officers were making life-or-death decisions without real-time data. Families were losing loved ones to overdoses because emergency responders couldn't identify the substances fast enough. Employers were waiting days for drug test results while impaired workers put everyone at risk.

We knew technology could solve this.

After 5+ years of R&D and working with some of the brightest minds in biosensor technology, we've created Narcolyzer™ the world's first portable, multi-drug breathalyzer. It detects opioids, THC, cocaine, methamphetamine, and more in under 5 minutes.

This isn't just a business. It's a mission to save lives.

Law enforcement agencies in 8+ states are asking for our technology, and we’re preparing for field-tested, breakthrough technology in 2026 that will redefine speed and accuracy in drug detection.

But we need your help to get there.

Whether you invest $100 or $10,000, you're not just backing a company you're backing a technology that will prevent tragedies, protect communities, and change the way we think about drug testing forever. Join us.

Mark Wong
CEO & Co-Founder, Epinal Inc.

Get Campaign Updates

Receive field-trial news, partnerships, and
funding progress

 CEO and co-founder of Epinal.

Hi, I'm Mark Wong, CEO and co-founder of Epinal.

Five years ago, my co-founder Mike and I asked ourselves a question Why is there no breathalyzer for narcotics?

We have alcohol breathalyzers. But when it comes to opioids, cocaine, THC substances killing thousands every year law enforcement has to wait days for lab results. Emergency responders can't identify what's causing an overdose in time to save lives. Employers are hiring people without knowing if they're impaired.

The Crisis We're Solving

The Crisis We're Solving

Drug-impaired driving, workplace accidents, and overdose deaths are at an all-time high. But the tools to detect narcotics are decades behind.

The Impaired Driving Epidemic

Drug-impaired driving is a growing public safety crisis. Law enforcement officers lack real-time roadside tools to detect narcotics—unlike alcohol breathalyzers which provide immediate results. Current testing limitations: Requires blood or urine samples and in some states requires a search warrant (invasive, refusable) Lab processing takes 24-72 hours Officers must rely on field sobriety tests (FSTs) and Drug Recognition Experts (DREs) Results arrive too late to prevent impaired drivers from getting back on the road

Workplace Safety at Risk

Employers in high-risk industries face delays of 3–7 days for lab testing. The result? Lost productivity, higher liability, and unsafe conditions. Companies need real-time results — not lab delays.

The Overdose Crisis

Over 100,000 Americans die from overdoses annually. Without knowing which drug caused it, first responders lose precious minutes. Narcolyzer identifies substances in under 5 minutes — enabling faster, life-saving care.

The World's First Portable, Multi-Drug Breathalyzer

The World's First Portable, Multi-Drug Breathalyzer

Non-invasive. Real-time results. Life-saving technology.

Narcolyzer is a breakthrough handheld breathalyzer that detects multiple narcotics simultaneously through a simple breath test. No needles. No urine cups. No waiting days for lab results. Just breathe — and get answers in minutes.

Our proprietary bio-inspired sensor technology mimics the molecular recognition systems found in nature, enabling accurate detection of:

  • THC & THC-A (marijuana)
  • Opiates (Fentanyl, heroin, morphine, codeine)
  • Cocaine
  • Benzodiazepines (Xanax, Valium)
  • MDMA (Ecstasy)
  • Methamphetamine
  • And their derivatives

Step 1: Insert Sensor Cartridge

Our removable, one-time-use sensor cartridge slides into the Narcolyzer device in seconds.

Step 2: Breathe Into Device

The user provides a breath sample similar to an alcohol breathalyzer. Completely non-invasive

Step 3: Get Instant Results

Within 3-5 minutes, results appear on-screen.

Who’s Asking for Narcolyzer

Who's Asking for Narcolyzer?

From law enforcement to Fortune 500 companies, the demand is overwhelming.

Law Enforcement Icon

Law Enforcement & First Responders

The Need: Police officers need real-time roadside testing to establish probable cause for narcotic impairment. Current methods require lab confirmation taking 24-72 hours, creating gaps in enforcement and investigation.

Narcolyzer's Impact: Enables immediate detection at traffic stops, DUI checkpoints, and crime scenes—giving officers the evidence they need to build stronger cases and improve public safety.

Early Interest: California Highway Patrol, Kentucky Highway Interdiction Team, Texas DPS Interdiction Teams, Metropolitan police departments in 8+ states,

Workplace Safety Icon

Workplace Safety & HR Compliance

The Need: Employers face two critical drug testing challenges: Pre-Employment Screening: Lab tests take 3-7 days, delaying hiring decisions Candidates accept other offers while waiting for results Slows workforce expansion in competitive labor markets Workplace Safety Testing: Pre-shift and post-shift testing for heavy machinery operators, drivers, and other safety-sensitive roles Post-accident testing to determine liability and prevent future incidents Random testing to maintain safety standards and reduce risk exposure

Narcolyzer's Impact: Conduct on-site testing with immediate results—reducing time-to-hire, preventing workplace accidents, and eliminating liability exposure. Pre and post-shift testing significantly reduces risk of impaired operation of heavy machinery and vehicles while protecting companies and saving lives.

Target Customers: Fortune 500 manufacturers, Construction companies, Oil & gas operators, Warehousing & logistics firms,

Transportation Icon

Transportation & Fleet Management

The Need: DOT regulations require commercial drivers to be drug-free. Current testing requires scheduled lab visits, disrupting operations and delaying compliance.

Narcolyzer's Impact: Pre and post-shift testing of all divers significantly reduces risk of impaired driving. Post accident testing can be conducted roadside without need for outside labs which can cause delays.

Target Customers: Trucking fleets (10,000+ drivers), Transit agencies (buses, rail), Ride-share & delivery companies,

Aviation Icon

Aviation & Aerospace Safety

The Need: Pilots, flight crews, and maintenance personnel must be substance-free before operating aircraft. Current testing requires lab appointments that cannot stop employees from piloting or working on planes while impaired.

Narcolyzer's Impact: Conduct pre, mid, and post-flight screenings in minutes at airports - ensuring flight safety without logistical delays.

Target Customers: Commercial airlines, Private aviation operators, Aerospace contractors,

Military Icon

Military & Defense Readiness

The Need: Military personnel require substance-free certification before deployment, special operations, and security clearance assignments. Current testing methods are slow and logistically complex in remote/field environments.

Narcolyzer's Impact: Portable, field-ready testing for pre-deployment screenings, random checks, and operational readiness verification.

Target Customers: U.S. Department of Defense, Special Operations Command, Defense contractors (Lockheed, Northrop Grumman).

Home Testing Icon

At-Home Testing & Family Safety

The Need: Parents want private, non-invasive ways to monitor adolescent substance use. Individuals in recovery programs need self-monitoring tools to prevent relapse.

Narcolyzer's Impact: Affordable, at-home breath testing empowers families to intervene early and support recovery - without stigma or invasive sample collection.

Target Customers: Parents of teenagers, Addiction recovery programs, Substance use treatment centers.

Testimonials:

FAQ Section - KickGoalz

Frequently Asked Questions

What is a SAFE, and how does it work?
A SAFE (Simple Agreement for Future Equity) is an investment contract that gives you the right to receive equity shares in Epinal at a future date typically when the company raises its next priced funding round (Series A, Series B) or undergoes a liquidity event (acquisition or IPO).
What is the minimum investment?
The minimum investment is $100. There is no maximum limit you can invest as much as you're comfortable with, up to the campaign's $2M maximum raise
How do I make money from this investment?
You make money when Epinal undergoes a liquidity event, such as: Acquisition: A larger company (e.g., Abbott, Dräger, Thermo Fisher) acquires Epinal. Your SAFE converts to equity, and you receive cash or stock based on the acquisition terms. IPO: Epinal goes public, and your shares become tradeable on public markets. Secondary sale: In some cases, investors may have opportunities to sell shares in private secondary markets before an IPO (typically after Series B/C rounds).
What are the risks of investing in Epinal?
Like all early-stage investments, investing in Epinal carries significant risk. Potential risks include: Product development delays: Field approval and field trial timelines may take longer than expected. Regulatory challenges: Medical device approval processes are complex and uncertain. Market adoption: Customers may be slower to adopt new technology than projected. Competition: Larger companies could enter the market with competing products. Funding risk: Epinal may need to raise additional capital, which could dilute your ownership.
When will Narcolyzer be available for purchase?
We are currently in the R&D and field trial phase. Our projected timeline is: 2026: Complete multi-state field trials and submit Field application 2027: Achieve Field clearance and launch limited commercial production 2028: Scale manufacturing and begin widespread sales
Is my investment tax-deductible?
No. Investments in Epinal are equity investments, not charitable donations, and are therefore not tax-deductible. However, you may be eligible for certain tax benefits under the Qualified Small Business Stock (QSBS) exemption if Epinal meets IRS criteria and you hold shares for 5+ years. Consult a tax advisor for details.
Image

Innovation

Fresh, creative solutions.

Image

Integrity

Honesty and transparency.

Excellence

Excellence

Top-notch services.

Copyright 2025. Epinal Inc. All Rights Reserved.